BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23895379)

  • 1. Polycystic ovaries - beyond menopause.
    Shah D; Bansal S
    Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.
    Krentz AJ; von Mühlen D; Barrett-Connor E
    Menopause; 2007; 14(2):284-92. PubMed ID: 17245231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
    Arentz S; Abbott JA; Smith CA; Bensoussan A
    BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes.
    García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A
    Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.
    Welt CK; Carmina E
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4629-38. PubMed ID: 24064685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity troponin-T levels and associated health conditions in 3146 women aged 46.
    Ollila MM; Arffman RK; Kaikkonen K; Morin-Papunen L; Junttila J; Piltonen TT
    Ann Med; 2023; 55(2):2264340. PubMed ID: 37795692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome.
    Amin M; Gragnoli C
    J Ovarian Res; 2023 Nov; 16(1):222. PubMed ID: 37993904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic aspects of the polycystic ovary syndrome.
    Randeva HS; Tan BK; Weickert MO; Lois K; Nestler JE; Sattar N; Lehnert H
    Endocr Rev; 2012 Oct; 33(5):812-41. PubMed ID: 22829562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus on women's health aspects of polycystic ovary syndrome (PCOS).
    Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
    Hum Reprod; 2012 Jan; 27(1):14-24. PubMed ID: 22147920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
    Hirschberg AL
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1202-1213. PubMed ID: 37886900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review.
    Choudhari R; Tayade S; Tiwari A; Satone P
    Cureus; 2024 Apr; 16(4):e58733. PubMed ID: 38779261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cardiovascular events in mothers of women with polycystic ovary syndrome.
    Cheang KI; Nestler JE; Futterweit W
    Endocr Pract; 2008 Dec; 14(9):1084-94. PubMed ID: 19158047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Dysfunction in Polycystic Ovary Syndrome.
    Banerjee S; Cooney LG; Stanic AK
    Immunohorizons; 2023 May; 7(5):323-332. PubMed ID: 37195871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome.
    Amin M; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3719-3732. PubMed ID: 37140321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome throughout a woman's life.
    Bellver J; Rodríguez-Tabernero L; Robles A; Muñoz E; Martínez F; Landeras J; García-Velasco J; Fontes J; Álvarez M; Álvarez C; Acevedo B;
    J Assist Reprod Genet; 2018 Jan; 35(1):25-39. PubMed ID: 28951977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study on the relationship between polycystic ovary syndrome and age at natural menopause.
    Amiri M; Rahmati M; Firouzi F; Azizi F; Ramezani Tehran F
    Menopause; 2024 Feb; 31(2):130-137. PubMed ID: 38411437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic Ovary Syndrome and the Forgotten Uterus.
    Hosseinzadeh P; Barsky M; Gibbons WE; Blesson CS
    F S Rev; 2021 Jan; 2(1):11-20. PubMed ID: 34423324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update.
    Profili NI; Castelli R; Gidaro A; Manetti R; Maioli M; Petrillo M; Capobianco G; Delitala AP
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.
    Yumiceba V; López-Cortés A; Pérez-Villa A; Yumiseba I; Guerrero S; García-Cárdenas JM; Armendáriz-Castillo I; Guevara-Ramírez P; Leone PE; Zambrano AK; Paz-Y-Miño C
    Front Endocrinol (Lausanne); 2020; 11():585130. PubMed ID: 33329391
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.